Literature DB >> 2229251

Determination of atracurium and laudanosine in human plasma by high-performance liquid chromatography.

F Varin1, J Ducharme, J G Besner, Y Théorêt.   

Abstract

A high-performance liquid chromatographic method coupled with fluorometric detection has been developed for the determination of atracurium and its major end-product laudanosine in human plasma. The method enables good separation of atracurium from its metabolites after direct precipitation of plasma proteins. The assay is sensitive, reproducible and linear for atracurium concentrations ranging from 31.25 to 8000 ng/ml. In a clinical setting, drugs commonly administered during anesthesia did not interfere with the assay. This method provides a simple and time-saving alternative to existing methods.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2229251     DOI: 10.1016/s0378-4347(00)83838-4

Source DB:  PubMed          Journal:  J Chromatogr


  4 in total

1.  Peripheral link model as an alternative for pharmacokinetic-pharmacodynamic modeling of drugs having a very short elimination half-life.

Authors:  J Laurin; F Donati; F Nekka; F Varin
Journal:  J Pharmacokinet Pharmacodyn       Date:  2001-02       Impact factor: 2.745

2.  Assuming peripheral elimination: its impact on the estimation of pharmacokinetic parameters of muscle relaxants.

Authors:  J Laurin; F Nekka; F Donati; F Varin
Journal:  J Pharmacokinet Biopharm       Date:  1999-10

3.  Residual curarization in the neonate after caesarean section.

Authors:  C Perreault; J Guay; P Gaudreault; L Cyrenne; F Varin
Journal:  Can J Anaesth       Date:  1991-07       Impact factor: 5.063

4.  Pharmacokinetic modelling of a parent drug and its metabolite. Atracurium and laudanosine.

Authors:  V Nigrovic; M Banoub
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.